ARTA
AMPE

A.R.T. Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

A.R.T. Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-140
Closed -$92K – 1814
2018
Q2 		$92K Sell
140
-114
-45% -$85.3K ﹤0.01% 1299
2018
Q1 		$258K Buy
+254
New +$213K 0.01% 1184
2017
Q2 		– Sell
-210
Closed -$50K – 1819
2017
Q1 		$50K Buy
+210
New +$56.4K ﹤0.01% 1328
2016
Q4 		– Sell
-52
Closed -$11K – 1438
2016
Q3 		$11K Sell
52
-44
-46% -$12.3K ﹤0.01% 618
2016
Q2 		$37K Sell
96
-71
-43% -$77.5K ﹤0.01% 1281
2016
Q1 		$112K Buy
+167
New +$112K 0.01% 1244

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

A.R.T. Advisors's AMPE Position: Q3 2018 in Review

A.R.T. Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2018, closing a stake of 140 shares — an estimated $92K sold.

A.R.T. Advisors first reported a position in AMPE in Q1 2016 and held it in 6 quarters. The position peaked at $258K in Q1 2018. 81 funds tracked by Wall St. Rank hold AMPE as of Q3 2018.

  • A.R.T. Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • A.R.T. Advisors sold 140 Ampio Pharmaceuticals Inc. shares in Q3 2018, an estimated $92K.
  • A.R.T. Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q1 2016 and held it in 6 quarters.
  • A.R.T. Advisors's Ampio Pharmaceuticals Inc. position peaked at $258K in Q1 2018.
  • 81 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2018.

Based on A.R.T. Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.